June 24, 2025
Metastasis. It’s the word cancer patients dread most – and the scan with ominous black spots showing the disease has spread. For too many people, metastatic cancer is kept at bay only for a short time, with chemotherapy and radiation, before the disease returns or the harsh treatments fatally weaken the body.For more than 20 years, Nancy Du, associate professor of pathology and laboratory medicine and the Rasweiler Family Research Scholar in Cancer Research at Weill Cornell Medicine, has researched how metastatic cancer arises. With a $500,000 grant over three years from the Congressionally...
June 14, 2025
Dr. Teresa Sanchez, associate professor of pathology and laboratory medicine and associate professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, has been awarded the highly competitive Established Investigator Award from the American Heart Association.
June 8, 2025
Neal Lindeman, M.D. is Vice Chair of Laboratory Medicine and Molecular Pathology, and Faculty Distinguished Professor in Pathology and Laboratory Medicine at Weill Cornell Medicine.Question: You completed your fellowship in molecular genetic pathology at Harvard Medical School. What drew you to that field? What did you find engaging and challenging about it?
June 8, 2025
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly.
April 29, 2025
Three distinguished Weill Cornell Medicine physician-scientists, Dr. Matthew Greenblatt, Dr. Lishomwa Ndhlovu and Dr. Sallie Permar, have been elected to the prestigious Association of American Physicians (AAP).Regarded as one of the top honors in the field of health and medicine, election to the AAP recognizes physician-scientists who exhibit excellence in the pursuit of medical knowledge and the advancement of basic or translational science through experimentation and discovery and its application to clinical medicine.
April 10, 2025
New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression. The study, published Feb.
January 16, 2025
Three Weill Cornell Medicine scientists were honored this week with the Presidential Early Career Award for Scientists and Engineers, the U.S. government’s highest commendation for outstanding early-career scientists and engineers.
December 4, 2024
The New York Pathological Society (NYPS), one of the country’s oldest societies devoted to pathology and various associated sciences, and its current Vice President, Dr. Sanjay Patel of the Weill Cornell Medicine (WCM) Department of Pathology and Laboratory Medicine, recently hosted a Fall Mini-Symposium at WCM.
November 25, 2024
The secret to cellular youth may depend on keeping the nucleolus—a condensed structure inside the nucleus of a cell—small, according to Weill Cornell Medicine investigators. The findings were elucidated in yeast, a model organism famous for making bread and beer and yet surprisingly similar to humans on the cellular level.
November 20, 2024
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine. The results could potentially lead to new therapies for patients with limited options and add to the significant progress the teams have made in understanding how advanced prostate cancer develops resistance to treatments that target androgen receptors.